摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dimethyl acetamidomalonate sodium salt | 72071-39-7

中文名称
——
中文别名
——
英文名称
dimethyl acetamidomalonate sodium salt
英文别名
——
dimethyl acetamidomalonate sodium salt化学式
CAS
72071-39-7
化学式
C7H10NNaO5
mdl
——
分子量
211.15
InChiKey
CFGPOVHURZTMBO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.84
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    65.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    dimethyl acetamidomalonate sodium salt4-(Bromomethyl)-2-(methoxymethyl)-5-propan-2-yl-1,2-oxazol-3-oneN,N-二甲基甲酰胺 为溶剂, 反应 14.0h, 以73%的产率得到Dimethyl 2-acetamido-2-[[2-(methoxymethyl)-3-oxo-5-propan-2-yl-1,2-oxazol-4-yl]methyl]propanedioate
    参考文献:
    名称:
    Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid
    摘要:
    We have previously proposed the existence of a lipophilic cavity of the 2-amino-3-(3-hydroxy-5-methylisoxazol4-yl)propionic acid (AMPA) receptor recognition site capable of accommodating alkyl substituents of limited size in the 5-position of the isoxazole ring. In order to indirectly elucidate the approximate extent of this proposed cavity we have synthesized and pharmacologically characterized a number of AMPA analogues. For most of these AMPA analogues, a positive correlation between AMPA receptor affinity and agonist effect was observed. The only exception was demethyl-AMPA (8a), which showed relatively high AMPA receptor affinity (IC50 = 0.27 mu M) but remarkably weak agonist potency (EC50 = 900 mu M). Whereas the ethyl analogue of AMPA (Et-AMPA) (IC50 = 0.030 mu M; EC50 = 2.3 mu M) has previously been shown to be slightly more potent than AMPA (IC50 = 0.040 mu M; EC50 = 3.5 mu M), substitutions of a propyl or a butyl group for the methyl group of AMPA to give 8b (IC50 = 0.090 mu M; EC50 = 5.0 mu M) or 8f (IC50 = 1.0 mu M; EC50 = 32 mu M), respectively, result in progressive loss of the AMPA agonist effect. Analogues containing larger groups, such as isopentyl (8e), 1-propylbutyl (8g), 2,2-dimethylpropyl (8h), or benzyl (14) groups, were very weak or totally inactive as AMPA receptor ligands.
    DOI:
    10.1016/s0223-5234(97)89085-x
点击查看最新优质反应信息

文献信息

  • Palladium-catalyzed asymmetric alkylation via π-allyl intermediate: Acetamidomalonate ester as a nucleophile.
    作者:Motowo Yamaguchi、Toshihide Shima、Takamichi Yamagishi、Mitsuhiko Hida
    DOI:10.1016/s0040-4039(00)97803-1
    日期:1990.1
    Asymmetric allylic alkylation of 1,3-diphenyl-2-propenyl acetate with sodium salt of acetamidomalonate ester has been carried out in the presence of a palladium catalyst containing (S)-BINAP to give a chiral α-allyl-αacetamidomalonate ester derivative of high optical purity (94±1% ee).
    在含有(S)-BINAP的钯催化剂的存在下,已将1,3-二苯基-2-丙烯基乙酸乙酸酯与乙酰氨基丙酸酯的钠盐进行不对称烯丙基烷基化反应,得到高光学纯度(94±1%ee)。
  • Construction of P-stereogenic center by selective ligation of NPN type ligands and application to asymmetric allylic substitution reactions
    作者:Takamichi Yamagishi、Masatoshi Ohnuki、Takahiro Kiyooka、Dai Masui、Kiyoshi Sato、Motowo Yamaguchi
    DOI:10.1016/j.tetasy.2003.09.004
    日期:2003.10
    Chiral bisoxazolylphosphine ligands 1 [(S,S)-PhP(Ox-R)(2): R = Me, Pr-i, Bu-t] with an N-P-N backbone were prepared from chiral 4-alkyl-2-phenyl-4,5-dihydrooxazole compounds. These ligands coordinated to Pd(II) ion as bidentate ligands selectively to give a stereogenic phosphorus atom. The Pd-(S,S)-PhP(Ox-Bu-t)(2) 1c catalyst evoked high enantioselectivity in asymmetric allylic substitutions of acyclic substrates using dimethyl sodiomalonate as nucleophile. In the reaction of 3-penten-2-yl acetate, which affords a pi-allyl intermediate with a small steric factor, the Pd-1c catalyst successfully induced very high enantioselectivity (94% ee) indicating the effectiveness of the P-stereogenic center formed by selective ligation of ligand 1. In the reaction of cyclic substrates, moderate to high enantioselectivity was obtained by Pd-1 catalyst using the sodium salt of dimethyl methylmalonate. (C) 2003 Elsevier Ltd. All rights reserved.
  • Palladium-assisted C-glycosylation. Addition of carbanions to cyclic enol ethers
    作者:Lois V. Dunkerton、Anthony J. Serino
    DOI:10.1021/jo00135a035
    日期:1982.7
  • Excitatory amino-acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid
    作者:F.A. Sløk、B Ebert、Y Lang、P Krogsgaard-Larsen、S.M. Lenz、U Madsen
    DOI:10.1016/s0223-5234(97)89085-x
    日期:1997.1
    We have previously proposed the existence of a lipophilic cavity of the 2-amino-3-(3-hydroxy-5-methylisoxazol4-yl)propionic acid (AMPA) receptor recognition site capable of accommodating alkyl substituents of limited size in the 5-position of the isoxazole ring. In order to indirectly elucidate the approximate extent of this proposed cavity we have synthesized and pharmacologically characterized a number of AMPA analogues. For most of these AMPA analogues, a positive correlation between AMPA receptor affinity and agonist effect was observed. The only exception was demethyl-AMPA (8a), which showed relatively high AMPA receptor affinity (IC50 = 0.27 mu M) but remarkably weak agonist potency (EC50 = 900 mu M). Whereas the ethyl analogue of AMPA (Et-AMPA) (IC50 = 0.030 mu M; EC50 = 2.3 mu M) has previously been shown to be slightly more potent than AMPA (IC50 = 0.040 mu M; EC50 = 3.5 mu M), substitutions of a propyl or a butyl group for the methyl group of AMPA to give 8b (IC50 = 0.090 mu M; EC50 = 5.0 mu M) or 8f (IC50 = 1.0 mu M; EC50 = 32 mu M), respectively, result in progressive loss of the AMPA agonist effect. Analogues containing larger groups, such as isopentyl (8e), 1-propylbutyl (8g), 2,2-dimethylpropyl (8h), or benzyl (14) groups, were very weak or totally inactive as AMPA receptor ligands.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物